FI72650C - Foerfarande foer framstaellning av en laongtidsverkande injektionsloesning av sulfadimetoxin. - Google Patents

Foerfarande foer framstaellning av en laongtidsverkande injektionsloesning av sulfadimetoxin. Download PDF

Info

Publication number
FI72650C
FI72650C FI802096A FI802096A FI72650C FI 72650 C FI72650 C FI 72650C FI 802096 A FI802096 A FI 802096A FI 802096 A FI802096 A FI 802096A FI 72650 C FI72650 C FI 72650C
Authority
FI
Finland
Prior art keywords
solution
pyrrolidone
sulfadimethoxine
benzyl alcohol
polyvinylpyrrolidone
Prior art date
Application number
FI802096A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI72650B (fi
FI802096A7 (fi
Inventor
William Wellesley Armstrong
Saurabhkumar Jayavantrai Desai
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI802096A7 publication Critical patent/FI802096A7/fi
Priority to FI863406A priority Critical patent/FI72651C/fi
Application granted granted Critical
Publication of FI72650B publication Critical patent/FI72650B/fi
Publication of FI72650C publication Critical patent/FI72650C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI802096A 1979-07-02 1980-07-01 Foerfarande foer framstaellning av en laongtidsverkande injektionsloesning av sulfadimetoxin. FI72650C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI863406A FI72651C (fi) 1979-07-02 1986-08-22 Foerfarande foer framstaellning av en laongtidsverkande injektionsloesning av sulfametazin.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5431379A 1979-07-02 1979-07-02
US5431379 1979-07-02

Publications (3)

Publication Number Publication Date
FI802096A7 FI802096A7 (fi) 1981-01-03
FI72650B FI72650B (fi) 1987-03-31
FI72650C true FI72650C (fi) 1987-07-10

Family

ID=21990197

Family Applications (1)

Application Number Title Priority Date Filing Date
FI802096A FI72650C (fi) 1979-07-02 1980-07-01 Foerfarande foer framstaellning av en laongtidsverkande injektionsloesning av sulfadimetoxin.

Country Status (10)

Country Link
EP (1) EP0021847B1 (enExample)
AT (1) ATE4166T1 (enExample)
DE (1) DE3064250D1 (enExample)
DK (1) DK283480A (enExample)
ES (1) ES8105146A1 (enExample)
FI (1) FI72650C (enExample)
GR (1) GR69205B (enExample)
IE (1) IE49934B1 (enExample)
NZ (1) NZ194192A (enExample)
ZA (1) ZA803937B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5980945A (en) * 1996-01-16 1999-11-09 Societe De Conseils De Recherches Et D'applications Scientifique S.A. Sustained release drug formulations
CN102772422B (zh) * 2012-08-22 2014-03-26 郑州福源动物药业有限公司 一种长效复方磺胺二甲嘧啶、巴喹普林注射液及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985876A (en) * 1973-01-05 1976-10-12 Burroughs Wellcome Co. Chemotherapeutic solutions containing a sulphur and a salt of a 2,4-diamino-5-benzylpyrimidine
GB1538903A (en) * 1975-04-11 1979-01-24 Nelson Res & Dev Carrier for a topically applied physiologically active agent or cosmetic agent
US4018889A (en) * 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
DK136934B (da) * 1976-02-06 1977-12-19 Rosco As Fremgangsmåde til fremstilling af en klar, stabil, injicerbar opløsning indeholdende et sulfonamid og en potentiator.
DE2631779A1 (de) * 1976-07-15 1978-01-19 Basf Ag Sulfonamid-trimethoprim-loesungen
IL52533A (en) * 1977-07-15 1980-01-31 Abic Ltd Injectable chloramphenicol composition

Also Published As

Publication number Publication date
EP0021847A3 (en) 1981-08-12
EP0021847B1 (en) 1983-07-20
ES493006A0 (es) 1981-06-01
DK283480A (da) 1981-01-03
DE3064250D1 (en) 1983-08-25
FI72650B (fi) 1987-03-31
GR69205B (enExample) 1982-05-07
ATE4166T1 (de) 1983-08-15
EP0021847A2 (en) 1981-01-07
ES8105146A1 (es) 1981-06-01
IE801363L (en) 1981-01-02
IE49934B1 (en) 1986-01-08
FI802096A7 (fi) 1981-01-03
NZ194192A (en) 1982-11-23
ZA803937B (en) 1981-06-24

Similar Documents

Publication Publication Date Title
EP1610613B1 (en) Topical anthelmintic veterinary formulations
BR9507640A (pt) Processo para estabilizar derivados de duocarmicida e composição farmacêutica
SK279290B6 (sk) Farmaceutická zmes na veterinárne použitie
DK304382A (da) Fremgangsmaade til fremstilling af substituerede imidazolderivater eller farmaceutisk acceptable syreadditionssalte deraf
DE68901153D1 (de) Derivate von purin, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
NO168048B (no) Dispersjonspolymerer, fremgangsmaate til deres fremstilling og deres anvendelse.
FI70138C (fi) Foerfarande foer framstaellning av en foerbaettrad injekterbarloesning innehaollande kalcium/magnesium/oxitetracyklinsa mklat
AU707366B2 (en) Long-acting oxytetracycline composition
FI72650B (fi) Foerfarande foer framstaellning av en laongtidsverkande injektionsloesning av sulfadimetoxin.
US4303643A (en) Sulfonamide compositions
FI71665C (fi) Foerfarande foer framstaellning av en flytande, injicerbar loesning av sulfonamid.
US4374826A (en) Sulfonamide compositions
FI72651B (fi) Foerfarande foer framstaellning av en laongtidsverkande injektionsloesning av sulfametazin.
JPS6431727A (en) Dissolution of argininamide and drug composition containing argininamides
FI57883B (fi) Foerfarande foer framstaellning av en stabil klortetracyklinloesning
JPH1135489A (ja) ポリオキシエチレン硬化ヒマシ油類の分解を防止した液剤
EP0008950A3 (en) Pyrimido(1,6-a)indole derivatives and intermediates therefor, processes for their preparation, pharmaceutical compositions containing the derivatives and their use
KR100486089B1 (ko) 암프롤륨, 설파퀴녹살린, 및 에토파베이트를 함유하는액상제제의 제조방법
KR970058711A (ko) 피부 질환 치료용 국소 조성물
KR910011258A (ko) 녹내장의 치료방법
SE418798B (sv) Antiinflammatorisk analgetisk gelad salva
HU188202B (en) Process for production of stabilized, injectable medical preparates consisting of - as reagents - 2-(4-)3-/2- chlorine-phentiazine-10-il/-propil)-1-piperazinil/-ethil /3,4,5-trimetoxi/benzoate-diethansulphonate
HK1081075A (en) Topical anthelmintic veterinary formulations
HK1081075B (en) Topical anthelmintic veterinary formulations

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: PFIZER INC.